1. In biopharma, M&A can be as larger as $8b like $ROG buyout of $ITMN. $PFE is willing to pay $17b for $HSP https://www.retailinvestor360.com/biotech/805-the-md-360-reports-on-corporate-strategy-of-pfizer-and-hospira-acquisition-deal.html

  2. Familiar ETF Friend Will Enjoy a Pharmacyclics Sale http://www.etftrends.com/2015/02/familiar-etf-friend-will-enjoy-a-pharmacyclics-sale/ $JNJ $NVWS $FBT $PCYC $ITMN

  3. $ITMN misses the Estimize EPS Consensus by 1c and the Estimize Revenue Consensus by $5.65M - http://www.estimize.com/itmn/fq4-2014?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

  4. $ITMN reports FQ4 earnings of -72c EPS and $35.70M Revs - http://www.estimize.com/itmn/fq4-2014?utm_content=release_actuals&utm_medium=tweet&utm_source=stocktwits

  5. $ITMN reports before the open tomorrow, Estimize Consensus +0.05 EPS and -1.51M Revs compared to WS http://www.estimize.com/itmn/fq4-2014?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

  6. This firm right here was a match made in heaven with Roche, the M&A that was imminent https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html $ITMN $ROG

  7. $MRTX It could be next $PBYI $ITMN http://www.mirati.com/programs/ Loved by Bakers they hold more than 19%

  8. Complete Dominancy In Fibrotic Lung Disease Market https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html $ITMN $ROG

  9. @MakeMyLuck I bought $ITMN at 10 before anyone knew what it was . Locked profit 14. It went to 75...small profit won t make you rich

  10. Bio Leading the Pack: Intercept, Regeneron, MannKind, InterMune & Sanofi. https://www.retailinvestor360.com/biotech/749-360-md-reports-on-biopharmas-leading-the-pack-intercept-regeneron-mannkind-intermune-and-sanofi.html $SNY $MNKD $REGN $ITMN $ICPT

  11. New bullish conversation activity in $ITMN. Had been quiet for past 48 hours.

  12. If anyone every say InterMune Inc, you say, Complete Dominance in Fibrotic Lungs Disease Market! $ITMN $ROG https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html

  13. The 360-MD Report has not failed to deliver for our 360-family of expert readers, that is! https://www.retailinvestor360.com/biotech/749-360-md-reports-on-biopharmas-leading-the-pack-intercept-regeneron-mannkind-intermune-and-sanofi.html $ICPT, $MNKD, $SNY, $ITMN

  14. $MNKD $ICPT $OME $ITMN $BRLI How to Be Opportune as Intelligent Investors in Chaotic Markets https://www.retailinvestor360.com/biotech/768-how-to-be-opportune-as-intelligent-investors-in-chaotic-markets.html

  15. $ITMN $ROG Forever treasures the sweet memories seeing how the thesis of InterMune unfolded, after years of waiting https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html

  16. Starting the merger and acquisition or buyout chat session at www.retailinvestor360 now. You can join me&ask your question $MNKD $ITMN $ROG

  17. Bought out by Roche $ROG, InterMune Inc $ITMN to Take Complete Dominancy In Fibrotic Lung Disease Market https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html

  18. $NPSP With GS in the loop, this could be another $ITMN story, looking towards higher 60s or maybe even lower 70s

  19. Bought out by Roche but $ITMN is one stock I ll never forget: Complete Dominancy In Fibrotic Lung Disease Market https://www.retailinvestor360.com/biotech/80-intermune-inc-complete-dominancy-in-fibrotic-lung-disease-market.html

  20. Revisiting 360-MD Reports on Biopharmas Leading the Pack: $REGN $MNKD $ITMN $SNY https://www.retailinvestor360.com/biotech/749-360-md-reports-on-biopharmas-leading-the-pack-intercept-regeneron-mannkind-intermune-and-sanofi.html

  21. $NPSP The sale process on NPSP could take couple of weeks by which I expect Natpara approval to be IN too .. Approval + Buyout aka $ITMN ..

  22. $NPSP could follow $ITMN trajectory!!

  23. @speedbirdd $ITMN was Roche s largest purchase: $8.3billion or $74 per share http://www.roche.com/media/media_releases/med-cor-2014-08-24.htm

  24. $IDRA Next $PCYC ,$ITMN

  25. $MACK this could go like $ITMN; uses biomarkers for drug platform, too